Korea, Republic ofOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 622 out of 105,998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 162,814 | 173,978 |
| Total Cites | 15,210 | 17,097 |
| H-index | 62 | 66 |
| Hm-index | 26 | 28 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 356 | 382 |
| Number of Single+First+Last Authored Papers | 227 | 227 |
| Total Cites to Single+First+Last Authored Papers | 5,813 | 6,329 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13,512 | 14,476 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.18 |
| Self-Citation Percentage |
11.04%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 604 out of 99,369 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 161,258 | 173,137 |
| Total Cites | 13,905 | 15,691 |
| H-index | 59 | 63 |
| Hm-index | 25 | 27 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 346 | 371 |
| Number of Single+First+Last Authored Papers | 220 | 220 |
| Total Cites to Single+First+Last Authored Papers | 5,230 | 5,711 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12,361 | 13,281 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.18 |
| Self-Citation Percentage |
11.38%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 595 out of 94,672 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 161,327 | 171,639 |
| Total Cites | 12,434 | 14,058 |
| H-index | 55 | 59 |
| Hm-index | 23 | 25 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 330 | 355 |
| Number of Single+First+Last Authored Papers | 217 | 217 |
| Total Cites to Single+First+Last Authored Papers | 4,592 | 5,046 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11,072 | 11,922 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.18 |
| Self-Citation Percentage |
11.55%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 636 out of 88,725 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 164,800 | 174,728 |
| Total Cites | 11,368 | 12,897 |
| H-index | 53 | 57 |
| Hm-index | 22 | 24 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 305 | 330 |
| Number of Single+First+Last Authored Papers | 200 | 200 |
| Total Cites to Single+First+Last Authored Papers | 4,187 | 4,604 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10,096 | 10,894 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.18 |
| Self-Citation Percentage |
11.86%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.